उत्पाद विवरण
Megval 50 mg Injection is a potent alkylating agent designed to combat various solid tumors, such as those found in breast and ovarian cancers, as well as multiple myeloma. By interfering with the DNA replication process in cancer cells, Megval effectively inhibits their growth and proliferation, thereby contributing to more favorable treatment outcomes. While it can be an essential part of cancer therapy, patients should be aware of potential side effects, including nausea, fatigue, and an increased risk of infection due to its impact on bone marrow function. It's crucial for patients to discuss their full medical history with their healthcare provider before starting treatment, as certain pre-existing conditions may require close monitoring. Additionally, regular blood tests may be necessary to assess blood cell counts during the treatment course. Megval is typically administered in a clinical setting, ensuring that patients receive the support they need throughout their therapy. As with any cancer treatment, adherence to the prescribed regimen and open communication with the healthcare team can significantly enhance the effectiveness of Megval. Always consult your healthcare professional for personalized advice and to address any concerns regarding this medication.
Reliable Hospital-Grade Sterile InjectionMegval 50 mg Injection is crafted as a sterile powder, ensuring optimal safety for hospital environments. Its recommended usage under the supervision of doctors guarantees precision in dosing and minimizes contamination risks. The product's robust packaging and clear labeling further aid in maintaining quality and traceability during clinical use.
Bulk Packaged for Healthcare ProvidersDistributed in vials containing 50 mg of sterile powder, Megval is delivered in batches of 100 pieces. This bulk packaging is suitable for high-demand hospital settings, minimizing logistical concerns and supporting streamlined inventory management for distributors and suppliers across India.
FAQ's of Megval 50 mg Injection:
Q: How is Megval 50 mg Injection administered?
A: Megval 50 mg is administered as an injection. The sterile powder must be reconstituted by trained healthcare professionals in a hospital setting and given according to a doctor's instructions.
Q: What are the benefits of using Megval 50 mg Injection in hospitals?
A: This injection offers precise dosing and tailored medical efficacy, ensuring safe and targeted patient treatment in controlled healthcare environments.
Q: When should Megval 50 mg Injection be used?
A: Megval 50 mg Injection is intended for use only when prescribed by a doctor, and is generally administered during hospital treatment for specific medical conditions requiring injectable therapy.
Q: Where can hospitals and clinics source Megval 50 mg Injection?
A: Hospitals and clinics can procure Megval 50 mg Injection in bulk from authorized distributors, exporters, suppliers, traders, and wholesalers throughout India.
Q: What is the process for preparing Megval 50 mg Injection for administration?
A: To prepare Megval 50 mg for use, the sterile powder is reconstituted with a suitable diluent by medical personnel following aseptic techniques prior to administration.
Q: Who is recommended to handle and administer this injection?
A: Only doctors or certified healthcare staff should handle and administer Megval 50 mg Injection, ensuring patient safety and proper therapeutic outcomes.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese